Skip to main content

Main menu

  • Pipeline
    • Clinical
    • Discovery
    • Compounds
    • Regimens
    • Drug Targets
    • Developers
    • Trial Sites
    • Trials
  • News
  • Meetings
  • Members
    • Our Members
    • Core Group
  • About
  • Join Us
Compound

Linezolid

Names
Chemical Class:
Oxazolidinone
Drug Target:
  • rRNA / Ribosome
Description
Linezolid is an FDA-approved drug for use against serious or problematic infections of resistant strains of gram-positive bacteria. It is currently under investigation as a repurposed drug for tuberculosis.

Related Links
  • Koh WJ, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS.2012.Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.J Antimicrob Chemother. Jun;67(6):1503-7.
Regimen Associations
Bedaquiline - Pretomanid - Linezolid - Moxifloxacin
Bedaquiline - Pretomanid - Linezolid
Bedaquiline-Moxifloxacin-Linezolid-Pyrazinamide
Trial Associations
TBTC Study 30: A Phase I/II Pilot Study for Evaluation of Low Dose, Once Daily, Linezolid Plus Optimized Background Therapy (OBT) Versus Placebo Plus OBT for the Treatment of Multi-drug Resistant Tube
TBTC Study 30PK Linezolid Pharmacokinetics and Pharmacodynamics in the Treatment of Multi-Drug Resistant and Extensively-Drug Resistant Tuberculosis
Nix-TB (B-Pa-L)
endTB
TB-PRACTECAL
ZeNix (B-Pa-L) NC-007
BEAT-TB Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis
endTB-Q
NC-009 Trial
DRAMATIC Trial
  Would you like to receive updates from the WGND? Join our mailing list:
Interests

About Us

Part of Stop TB Partnership, we are a network of committed individuals devoted to accelerating the development of effective, affordable new therapies for TB.

Visit the Stop TB Partnership
Read about The Global Plan to End TB

Navigate

  • Clinical Pipeline
  • Discovery
  • Developers
  • Trials
  • Trial Sites
  • News
  • Meetings
  • Core Group
  • Members
  • About

Contact

The Working Group for New TB Drugs

80 Pine Street, Fl 20th
New York, NY

Contact Us

Follow Us

©2016 Working Group on New TB Drugs. All Rights Reserved. Terms of Reference Site by Darby Communications